These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

491 related items for PubMed ID: 14527520

  • 1. Intradermal inoculations of low doses of Leishmania major and Leishmania amazonensis metacyclic promastigotes induce different immunoparasitic processes and status of protection in BALB/c mice.
    Courret N, Lang T, Milon G, Antoine JC.
    Int J Parasitol; 2003 Oct; 33(12):1373-83. PubMed ID: 14527520
    [Abstract] [Full Text] [Related]

  • 2. The levels and patterns of cytokines produced by CD4 T lymphocytes of BALB/c mice infected with Leishmania major by inoculation into the ear dermis depend on the infectiousness and size of the inoculum.
    Lang T, Courret N, Colle JH, Milon G, Antoine JC.
    Infect Immun; 2003 May; 71(5):2674-83. PubMed ID: 12704142
    [Abstract] [Full Text] [Related]

  • 3. Is the reactive oxygen species-dependent-NF-kappaB activation observed in iron-loaded BALB/c mice a key process preventing growth of Leishmania major progeny and tissue-damage?
    Bisti S, Soteriadou K.
    Microbes Infect; 2006 May; 8(6):1473-82. PubMed ID: 16702015
    [Abstract] [Full Text] [Related]

  • 4. Despite increased CD4+Foxp3+ cells within the infection site, BALB/c IL-4 receptor-deficient mice reveal CD4+Foxp3-negative T cells as a source of IL-10 in Leishmania major susceptibility.
    Nagase H, Jones KM, Anderson CF, Noben-Trauth N.
    J Immunol; 2007 Aug 15; 179(4):2435-44. PubMed ID: 17675505
    [Abstract] [Full Text] [Related]

  • 5. CD8+ T cells are required for primary immunity in C57BL/6 mice following low-dose, intradermal challenge with Leishmania major.
    Belkaid Y, Von Stebut E, Mendez S, Lira R, Caler E, Bertholet S, Udey MC, Sacks D.
    J Immunol; 2002 Apr 15; 168(8):3992-4000. PubMed ID: 11937556
    [Abstract] [Full Text] [Related]

  • 6. Lack of signaling by IL-4 or by IL-4/IL-13 has more attenuating effects on Leishmania amazonensis dorsal skin--than on footpad-infected mice.
    Felizardo TC, Gaspar-Elsas MI, Lima GM, Abrahamsohn IA.
    Exp Parasitol; 2012 Jan 15; 130(1):48-57. PubMed ID: 22019418
    [Abstract] [Full Text] [Related]

  • 7. Leishmania tropica: suggestive evidences for the effect of infectious dose on pathogenicity and immunogenicity in an experimental model.
    Rostamian M, Jafari D, Abolghazi M, Farahani H, Niknam HM.
    Parasitol Res; 2018 Sep 15; 117(9):2949-2956. PubMed ID: 29978420
    [Abstract] [Full Text] [Related]

  • 8. A natural model of Leishmania major infection reveals a prolonged "silent" phase of parasite amplification in the skin before the onset of lesion formation and immunity.
    Belkaid Y, Mendez S, Lira R, Kadambi N, Milon G, Sacks D.
    J Immunol; 2000 Jul 15; 165(2):969-77. PubMed ID: 10878373
    [Abstract] [Full Text] [Related]

  • 9. Leishmania major reaches distant cutaneous sites where it persists transiently while persisting durably in the primary dermal site and its draining lymph node: a study with laboratory mice.
    Nicolas L, Sidjanski S, Colle JH, Milon G.
    Infect Immun; 2000 Dec 15; 68(12):6561-6. PubMed ID: 11083765
    [Abstract] [Full Text] [Related]

  • 10. Leishmania pifanoi pathogenesis: selective lack of a local cutaneous response in the absence of circulating antibody.
    Colmenares M, Constant SL, Kima PE, McMahon-Pratt D.
    Infect Immun; 2002 Dec 15; 70(12):6597-605. PubMed ID: 12438331
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Vaccine-induced protection against Leishmania amazonensis is obtained in the absence of IL-12/23p40.
    Hernández MX, Barçante TA, Vilela L, Tafuri WL, Afonso LC, Vieira LQ.
    Immunol Lett; 2006 May 15; 105(1):38-47. PubMed ID: 16466810
    [Abstract] [Full Text] [Related]

  • 13. The prevention of the growth of Leishmania major progeny in BALB/c iron-loaded mice: a process coupled to increased oxidative burst, the amplitude and duration of which depend on initial parasite developmental stage and dose.
    Bisti S, Konidou G, Boelaert J, Lebastard M, Soteriadou K.
    Microbes Infect; 2006 May 15; 8(6):1464-72. PubMed ID: 16698303
    [Abstract] [Full Text] [Related]

  • 14. The potency and durability of DNA- and protein-based vaccines against Leishmania major evaluated using low-dose, intradermal challenge.
    Méndez S, Gurunathan S, Kamhawi S, Belkaid Y, Moga MA, Skeiky YA, Campos-Neto A, Reed S, Seder RA, Sacks D.
    J Immunol; 2001 Apr 15; 166(8):5122-8. PubMed ID: 11290794
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Leishmania (Leishmania) amazonensis infection and dissemination in mice inoculated with stationary-phase or with purified metacyclic promastigotes.
    Felizardo TC, Toma LS, Borges NB, Lima GM, Abrahamsohn IA.
    Parasitology; 2007 Nov 15; 134(Pt 12):1699-707. PubMed ID: 17655808
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.